MarketPeel
Pricing
…
Chief Financial Officer
Benjamin Hohl
Tue, Apr 4, 2023
Apr 4
received an award in ELVN
206,000 shares @ $0.00
New position
ELVNEnliven Therapeutics, Inc.
HealthcareBiotechnology
1D0.00%
1W+1.80%
1M+15.49%
3M+47.67%
6M—
1Y—

Recent insider activity at ELVN

Aug 17Benjamin HohlSold$270.17kAug 17Helen Louise CollinsSold$227.65kAug 17Helen Louise CollinsSold$65.28kAug 17Benjamin HohlSold$82.38kAug 4Mika K. DerynckSold$9.56mJul 17Benjamin HohlSold$134.14kJul 17Benjamin HohlSold$140.82kJul 17Benjamin HohlSold$16.19k
Full ELVN profile →Benjamin Hohl’s trading history →
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback